FUM — Futura Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- £109.12m
- £101.41m
- £3.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.1 | -2.93 | -5.87 | -6.87 | -6.89 |
Depreciation | |||||
Non-Cash Items | 0.079 | 0.148 | 0.182 | 0.672 | 2.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.39 | -1.79 | 1.79 | 0.399 | 4.63 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6.66 | -4.54 | -3.87 | -5.78 | 0.57 |
Capital Expenditures | -0.033 | -0.008 | -0.42 | -0.741 | -1.51 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.022 | 0.001 | 0 | — | 0.072 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.01 | -0.007 | -0.42 | -0.741 | -1.43 |
Financing Cash Flow Items | 0 | -0.212 | -0.672 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0.019 | 3.06 | 13.6 | 0.17 | 4.55 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6.65 | -1.49 | 9.35 | -6.35 | 3.69 |